Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupAcute LeukemiasMyeloproliferative neoplasms (MPN) and myelodysplastic neoplasms (MDS)TransplantationDiseaseAcute Lymphoblastic LeukaemiaAcute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic NeoplasmsStem Cell Transplantation, AllogeneicSubgroupICD10C91.0-C92.0-C92.1-C92.5-C92.6-C92.7-C92.8-C92.9-C93.0-D46.-MeSHHematopoietic Stem Cell TransplantationPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaTransplantation ConditioningSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronUrsodeoxycholic acidValaciclovirNo. Substances10Protocol classificationTherapy classificationcurrent standardIntensityKonditionierung, myeloablativ (MAC)Konditionierung, nicht-myeloablativ (NMA)Therapy indicationTherapy phaseallogene StammzelltransplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorBlume KGKornblit BDiseaseAML/ALL/CML, allogene StammzelltransplantationAML/MDS, ALL, allogene StammzelltransplantationOriginCity of Hope National Medical Center, California, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WashingtonProtokolle in Überarbeitung 2 protocols foundEtoposide Phosphate 60 / TBI 13.2, Allogeneic Stem Cell Transplantation, MAC (PID3221 V1.0)Fludarabine 30 / TBI 2, Allogeneic Stem Cell Transplantation, NMA (PID3222 V1.0)
